A randomized phase II clinical trial of tailored CPT-11 + S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/15333687

Download in:

View as

General Info

PMID
15333687